It can affect glucose metabolism by blocking the activation of the anabolic enzyme Akt or protein kinase B (Akt/PKB), inhibiting insulin signaling, and inducing selective insulin resistance, which hinders glucose uptake and storage and promotes hepatic gluconeogenesis [51–53]. The gene discussed is INS; the disease is Insulin resistance.